We are live on ! Find out more
HW

Hancock Whitney Portfolio holdings

AUM $5.75B
1-Year Est. Return 24.3%
This Fund
S&P 500
This Quarter Est. Return
+15.34%
1 Year Est. Return
+24.3%
3 Year Est. Return
+81.4%
5 Year Est. Return
+108.63%
10 Year Est. Return
+431.68%
AUM
$3B
AUM Growth
+$287M
Cap. Flow
-$66.1M
Cap. Flow %
-2.21%
Top 10 Hldgs %
24.5%
Holding
873
New
93
Increased
173
Reduced
475
Closed
83

Top Buys

Rank Stock Value
1
CLX icon
Clorox
CLX
+$13.6M
2
MNST icon
Monster Beverage
MNST
+$13.1M
3
BERY
Berry Global Group, Inc.
BERY
+$10.5M
4
QCOM icon
Qualcomm
QCOM
+$9.98M
5
SYNA icon
Synaptics
SYNA
+$9.85M

Top Sells

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$19M
2
LHX icon
L3Harris
LHX
+$16.9M
3
ALB icon
Albemarle
ALB
+$15.8M
4
KO icon
Coca-Cola
KO
+$14.3M
5
TXN icon
Texas Instruments
TXN
+$11.3M

Sector Composition

Rank Sector Weight
1 Technology 16.72%
2 Financials 12.19%
3 Healthcare 11.14%
4 Industrials 8.82%
5 Consumer Discretionary 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RING icon
626
iShares MSCI Global Gold Miners ETF
RING
$2.22B
$311K 0.01%
10,441
-5,776
-36% -$179K
USNA icon
627
Usana Health Sciences
USNA
$417M
$309K 0.01%
4,003
+1
+0% +$77
XLNX
628
DELISTED
Xilinx Inc
XLNX
$305K 0.01%
2,154
-485
-18% -$63.1K
SJM icon
629
J.M. Smucker
SJM
$13.6B
$304K 0.01%
+2,630
New +$306K
NUVA
630
DELISTED
NuVasive, Inc.
NUVA
$303K 0.01%
5,387
-293
-5% -$14.4K
BMRN icon
631
BioMarin Pharmaceuticals
BMRN
$11.9B
$302K 0.01%
3,440
-208
-6% -$16.5K
EPD icon
632
Enterprise Products Partners
EPD
$83.8B
0
JBHT icon
633
JB Hunt Transport Services
JBHT
$25.6B
$300K 0.01%
2,196
TBRG
634
DELISTED
TruBridge
TBRG
$294K 0.01%
10,961
-668
-6% -$18.9K
BNY
635
Bank of New York Mellon
BNY
$104B
$293K 0.01%
+6,892
New +$265K
CTRE icon
636
CareTrust REIT
CTRE
$10B
$293K 0.01%
13,200
-188
-1% -$3.7K
ADSK icon
637
Autodesk
ADSK
$52B
$292K 0.01%
955
-40
-4% -$10.5K
ETR icon
638
Entergy
ETR
$51.3B
$292K 0.01%
5,852
-22
-0.4% -$1.16K
GVI icon
639
iShares Intermediate Government/Credit Bond ETF
GVI
$3.77B
$289K 0.01%
2,453
+275
+13% +$32.3K
IP icon
640
International Paper
IP
$22.7B
$289K 0.01%
6,152
-15,115
-71% -$676K
CBSH icon
641
Commerce Bancshares
CBSH
$8.72B
$288K 0.01%
5,603
NIO icon
642
NIO
NIO
$11.9B
$288K 0.01%
+5,906
New +$228K
OMC icon
643
Omnicom Group
OMC
$23.7B
$288K 0.01%
+4,617
New +$264K
LULU icon
644
lululemon athletica
LULU
$13.5B
$287K 0.01%
825
ZION icon
645
Zions Bancorporation
ZION
$10.1B
$284K 0.01%
+6,532
New +$242K
MED icon
646
Medifast
MED
$107M
$283K 0.01%
1,442
-92
-6% -$16.3K
SYF icon
647
Synchrony
SYF
$24.7B
$283K 0.01%
+8,152
New +$245K
GLDD
648
DELISTED
Great Lakes Dredge & Dock
GLDD
$282K 0.01%
21,378
-896
-4% -$10K
EIX icon
649
Edison International
EIX
$30.5B
$281K 0.01%
4,478
-240
-5% -$14.5K
IVZ icon
650
Invesco
IVZ
$12.4B
$280K 0.01%
+16,055
New +$247K

Similar funds

Hancock Whitney's Q4 2020 Portfolio in Review

As of Q4 2020, Hancock Whitney held 873 positions worth $3B, up 11% from $2.71B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Hancock Whitney's Q4 2020 filing shows 93 new, 173 increased, 475 reduced and 83 closed positions. Its largest new stake was Monster Beverage: 311,766 shares worth $14.4M. The largest sale was Estee Lauder, an estimated $19M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Hancock Whitney's largest Q4 2020 buy was Monster Beverage: 311,766 shares worth $14.4M.
  • Hancock Whitney added most to Clorox in Q4 2020, an estimated $13.6M increase.
  • Hancock Whitney's biggest Q4 2020 reduction was Estee Lauder, cutting an estimated $19M.
  • Hancock Whitney fully exited Citrix Systems Inc in Q4 2020, selling an estimated $6.72M.
  • Hancock Whitney's ten largest holdings make up 24% of its $3B portfolio in Q4 2020.
  • Hancock Whitney opened 93 new positions and closed 83 in Q4 2020.
  • Hancock Whitney's portfolio value rose 11% quarter-over-quarter to $3B.

Based on Hancock Whitney's 13F filing for Q4 2020, filed 9 Feb 2021.